The Compensation Of Medical Institutions And Drug Price Linkage Mechanism Research

Since the90s of last century, all countries’medical and health costs continued grow rapidly for the excessive growth of drug cost, which not only occupied a lot of government budgets, but also put a heavy financial burden on the countries’economy. To ordinary patients, excessive growth of drug cost let them feel "it’s too difficult and expensive to see a doctor". This problem becomes more and more seriously in recent years. While, how to crack the problem gives the major experts and scholars a headache. In this paper, through deeply studying present situation of China’s medical institutions compensation mechanism, we discover that medical institutions are forced to increase revenue due to the lack of full financial compensation for policy-related losses. China’s previous health-care reforms are failed due to lacking of a fair and effective medical compensation system and strictly rational drug pricing system. The fail reforms result in accelerating drug costs rising trend, which also spur China’s health expenses continued rise.Now China’s "new medical reform" goes ahead step by step and the medical and health system reform has entered in a crucial stage, the reform faces the problem how to universally achieve health insurance and how to universally achieve urban and rural residents medical insurance after eliminating urban-rural dual structure in limited medical costs, which is a huge century problems. We should fully understand the challenge that the linkage between medical institutions compensation and drug price is facing at this stage. We also should fully understand the necessity, importance and urgency of the linkage between medical institutions compensation and drug price. Well linkage between medical institutions and drug price drug price model design will contribute to realize China’s "new medical reform" pledged targets.In this paper, we focus on China medical institutions’compensation system and drug pricing system, through literature research, questionnaires, key personnel depth interviews, case studies and other methods. We use AHP, mathematical logic and mathematical derivation method to reveal China medical institutions distortion compensation Present Situation. Using signal model analysis and competitor game analysis method to find the essential reason for strong drug price after too many times drug price adjustment. We proposed new medical institutions compensation mechanism and drug pricing mechanism by linking the medical institution compensation and drug pricing mechanism.First,we analyze the health care system and medical institutions compensation mechanism in macro and micro levels.The analyze report reveals that medical institutions are forced to use drugs and medical services revenue to make up for deficit because of lacking of enough financial compensation.Second,we use mathematical reasoning analysis method analyze the main three drug price policy so that we can give advice to each drug pricing policy.Then we analyze China drug value chain problems by using Competitors game theory in medical institution compensation,drug value chain economic analysis and depth relevant person interviews.At the end of the paper, the writer put forward the idea of well linkage between medical institutions compensation and drug price. Then, using the pilot experience and data in certain area to test and demonstrate the necessity and urgency of the linkage mechanism as well as the feasibility of the idea.